Abstract
Introduction
The nicotinic acetylcholine receptor (AChR) isolated from the electroplacque tissue of the marine elasmobranch Torpedo californica is a ligand activated cation-speci¢c ion channel. The 290 kDa membrane-imbedded pentamer consists of four unique subunits, with a stoichiometry of K 2 LQN (for recent reviews, see [1, 2] ). Similar hydropathy pro¢les and considerable sequence homology among the AChR subunits serve as the basis for a predicted folding topology consisting of four hydrophobic membrane spanning K-helical segments referred to as M1, M2, M3 and M4 [3, 4] . Substantial experimental evidence supports the pentameric subunit arrangement [5] and the M1^M4 folding of the lipid imbedded regions of AChR subunits (reviewed in [6] ).
The binding of acetylcholine to sites on the extracellular domains of the AChR leads to the transient opening of a cation-selective ion channel. In the continued presence of agonist, the AChR isomerizes to a non-conducting,`desensitized' conformation. Studies involving reconstituting puri¢ed AChRs into membranes of de¢ned lipid composition have shown that these agonist-induced conformational transitions are highly sensitive to the presence of both cholesterol and negatively charged phospholipids [7^10] . The use of a variety of spin-labeled lipids has established that in accordance with the abundance of cholesterol and negatively charged phospholipids in native-receptor rich membranes [11, 12] these lipids preferentially interact with the AChR [13^15] . The use of a brominated steroid analog in £uorescence quenching studies revealed the presence of two di¡erent lipid binding domains for the AChR [16] ; annular sites (approximately 45 per AChR) which bind both sterol and phospholipids and non-annular sites (5^10 sites per AChR) which have a 20-fold higher a¤nity for cholesterol. Photoa¤nity labeling studies with both anionic lipid [17, 18] and cholesterol [19, 20] analogs have further demonstrated a direct interaction of these lipids with the AChR.
The presence of cholesterol has been shown to be required for AChR function and a direct speci¢c interaction with the receptor has been well documented. However, identi¢cation of the region(s) in the AChR primary structure which contribute to the formation of the binding site for cholesterol is an important step in obtaining a more complete understanding of the role of this lipid in regulating AChR structure and function. Here, we provide the ¢rst evidence of this type by mapping the labeling of a photoactivatable cholesterol analog, 3K-(4-azido-3-[ 125 I]iodosalicylic)-cholest-5-ene ([ 125 I]azido-cholesterol), to the membrane imbedded regions of the Torpedo californica AChR. We further provide a model of cholesterol action that involves cholesterol binding to the interfaces of the lipid-exposed transmembrane segments and by facilitating the subtle movements of these domains helping to mediate the conformational transitions of the AChR.
Materials and methods

Materials
3K-(4-Azido-3-[
125 I]-iodosalicylic)-cholest-5-ene ([  125 I ]azido-cholesterol) was prepared by coupling 3K-aminocholest-5-ene and 4-azido salicylic acid using dicyclohexylcarbodiimide, followed by chloramine T iodination and puri¢cation by reverse-phase thin-layer chromatography (TLC) [21] . [
125 I]Azidocholesterol was stored in methanol (V10 Ci/mmol, 70 WCi/ml) at 4³C in the dark. Staphylococcus aureus V8 protease was obtained from ICN Biochemicals and L-1-tosylamido-2-phenylethyl chloromethyl ketone (TPCK)-treated trypsin from Worthington Biochemical. Genapol C-100 (10% w/v) was purchased from Calbiochem and sodium cholate from Sigma. Asolectin (a crude soybean lipid extract) came from Avanti Polar Lipids.
AChR-rich membranes
AChR-rich membranes were isolated from the electric organ of Torpedo californica (Aquatic Research Consultants, San Pedro, CA) according to the procedure of Sobel et al. [22] , with the modi¢ca-tions described previously [23] . The ¢nal membrane suspensions in 36% sucrose/0.02% NaN 3 were stored at 380³C.
A¤nity column puri¢cation and reconstitution of AChR membranes
The Torpedo AChR was isolated from detergent (cholate) extracts of crude AChR membranes by af¢nity chromatography in the presence of asolectin lipids. A¤nity column puri¢cation was performed using an acetylcholine a¤nity matrix according to the procedure of Ellena et al. [14] with several modi¢cations according to the methods outlined in Blanton and Wang [17] . Brie£y, the a¤nity column matrix was prepared by coupling cystamine to A¤-gel 10 (Bio-Rad), reduction with dithiothreitol and ¢nal modi¢cation with bromoacetylcholine bromide. Af¢nity-puri¢ed AChRs were reconstituted with asolectin at a lipid protein ratio of 800:1 on a mole per mole basis and stored at 380³C.
[ 125 I]Azido-cholesterol labeling of AChR membranes
To introduce the photoa¤nity probe into AChRrich membranes, typically 20 WCi (V1.25 nmol) of [ 125 I]azido-cholesterol (methanolic stock solution) was dried on the inside of a 10U75 mm glass test tube with a stream of nitrogen. AChR-rich membranes (4 mg/ml) in vesicle dialysis bu¡er (VDB, 100 mM NaCl, 0.1 mM EDTA, 0.02% NaN 3 , 10 mM MOPS pH 7.5) were solubilized with sodium cholate at a ¢nal concentration of 1% (2 mg/ml protein) at 4³C for 1 h (constant stirring). Insoluble material was removed by centrifugation at 39 000Ug for 1 h at 4³C. The solubilized material (supernatant) was added to the test tube containing a dried layer of [
125 I]azido-cholesterol (¢nal concentration V2.5 WM) and mixed thoroughly. Following a 30 min incubation, the solution was divided into two aliquots and carbamylcholine (250 WM) added to one sample. Following a 1 h incubation the membrane suspensions were irradiated at 365 nm (Spectroline EN-280L) for 7 min at a distance of 6 1 cm. All operations, unless speci¢ed otherwise, were performed under reduced lighting conditions and at room temperature. Photolyzed material was then solubilized in electrophoresis sample bu¡er and subjected to SDS-PAGE.
An alternate method was used to incorporate [ 125 I]azido-cholesterol into a¤nity-puri¢ed AChRs that have reconstituted into lipid (asolectin) vesicles. Asolectin (1 mg in dichloromethane) was dried onto the surface of a glass test tube with a stream of nitrogen. To this was added either 20 WCi (analytical labeling) or 100 WCi (preparative labeling) of [ 125 I]azido-cholesterol and the organic solvent removed under a stream of nitrogen. VDB bu¡er was then added, the solution layered with nitrogen, and the tube sealed. The solution was vortexed for 15 min followed by 60 min of gentle sonication. A¤nity puri¢ed reconstituted AChRs (0.2 mg for analytical and 1.6 mg for preparative labelings) were added to the tube containing [
125 I]azido-cholesterol. The test tube was then sealed in the presence of nitrogen and the membrane suspension incubated overnight at 5³C. Following overnight incubation, carbamylcholine (250 WM) was added to appropriate samples and allowed to equilibrate for 1 h. The samples were irradiated as described above, the membranes pelleted (39 000Ug for 1 h), solubilized in electrophoresis sample bu¡er and subjected to SDS-PAGE.
SDS-PAGE
SDS-PAGE was performed according to the method of Laemmli [24] with analytical (1.0 mm thick) and preparative (1.5 mm) separating gels comprised of 8% polyacrylamide/0.33% bis-acrylamide. Following electrophoresis, AChR subunits were visualized by staining with Coomassie blue R-250 (0.25% (w/v) in 45% methanol, 10% acetic acid, 45% dH 2 O) and destaining (25% methanol, 10% acetic acid, 65% dH 2 O). Stained gels were soaked in distilled water overnight and the AChR K, L, Q, and N bands for each labeling condition (3/+ carbamylcholine) were excised and transferred to either a 1.0 or 1.5 mm (preparative) thick 15% acrylamide mapping gel [25, 23] . For analytical labelings, each gel slice was overlaid with a solution containing S. aureus V8 protease (6 Wg) and electrophoresed at 50 V constant voltage for V3 h and then at 5 mA constant current overnight. After Coomassie blue R-250 staining (2 h) and destaining (3^4 h), analytical gels were dried and exposed to Kodak X-OMAT ¢lm with an intensifying screen at 380³C. Preparative 8% acrylamide gels (1.5 mm thick) were soaked in distilled water overnight and the K-and Q-subunits excised as an approximately V14 cm strip. The strips were transferred to individual 15% acrylamide mapping gels and overlaid with 200 Wg V8 protease. Following electrophoresis and staining (same as analytical gel conditions), the subunit fragment bands KV8-20 (KSer-173-Glu-338), KV8-10 (KAsn-339-Gly-437), and QV8-14 (QLeu-373-Pro-489) were excised and the polypeptides eluted into 15 ml of Elution bu¡er (0.1 M NH 4 HCO 3 , 0.1% (w/v) SDS, 1% L-mercaptoethanol, pH 7.8) for 4 days at room temperature with gentle mixing [26, 27] . The gel suspensions were then ¢ltered through Whatman no. 1 paper and concentrated using a Centriprep-10 (Amicon). Excess SDS was removed by acetone precipitation (85% acetone at 320³C for V18 h).
Isolation of [ 125 I]azido-cholesterol labeled fragments
For digestion with trypsin, acetone precipitated V8 protease subunit fragments, KV8-20, KV8-10, and QV8-14 were resuspended in approximately 300 Wl of 0.1 M NH 4 HCO 3 , 0.02% (w/v) SDS, 0.5% Genapol C-100, pH 7.8 (1^2 mg/ml protein). Trypsin was added at a 100% (w/w) enzyme to substrate ratio and the digestion allowed to proceed 4 days at room temperature. The digests were then separated by reverse-phase HPLC using a Brownlee Aquapore C 4 column (100U2.1 mm) with solvent A (0.08% TFA in water), solvent B (0.05% TFA in 60% acetonitrile/ 40% 2-propanol). A non-linear elution gradient was employed (25^100% solvent B in 80 min) and the elution of peptides was monitored by the absorbance at 210 nm. Collected fractions were counted for radioactivity in a Packard Cobra II Gamma Counter and the peak protein/radioactivity-containing fractions were pooled, dried by vacuum centrifugation, and resuspended in 20 Wl of 0.1 M NH 4 HCO 3 , 0.1% (w/v) SDS, pH 7.8 for protein sequence analysis.
Sequence analysis
Amino terminal sequence analysis was performed on a Beckman Instruments (Porton) 20/20 automated protein sequencer using gas phase cycles (Texas Tech Biotechnology Core Facility). Peptide aliquots (20 Wl) were immobilized on chemically modi¢ed glass ¢ber disks (Beckman Instruments), which were used to improve the sequencing yields of hydrophobic peptides, and subjected to 10 sequencing cycles. The K-M4 peptide, from HPLC puri¢ed tryptic digest of KV8-10, was radiosequenced on an Applied Biosystems model 477A protein sequencer using gas phase cycles (in the laboratory of Dr. Jonathan B. Cohen, Department of Neurobiology, Harvard Medical School). Approximately 30% of the release PTHamino acids were separated by an on-line Model 120A PTH-amino acid analyzer, and approximately 60% was collected for determination of released 125 I by Q-counting of each sample for 45 min. Initial yield (I o ) and repetitive yield (R) were calculated by nonlinear least-squares regression of the observed release (M) for each cycle (n): M = I o R n (PTH-derivatives of Ser, Thr, Cys, and His were omitted from the ¢t).
Results
Characterization of [ 125 I]azido-cholesterol labeling of AChR subunits
Initial attempts to introduce the cholesterol photoa¤nity analog [
125 I]azido-cholesterol ( Fig. 1) into AChR-rich membranes by addition of an aliquot of a methanolic stock solution proved unsatisfactory. With a 2 h incubation less than 25% of the [ 125 I]azido-cholesterol probe remained associated with the AChR-rich membranes following irradiation and centrifugation. Subsequent experiments revealed that the labeling e¤ciency was greatly improved by incubating probe that has been dried against the walls of a glass test tube with detergent (cholate)-solubilized AChR-rich membranes. Previous studies have shown that cholate solubilized AChRs retain their ability to undergo agonist-induced conformational transitions and in the absence of agonist the receptor remains in the resting state ( [28] ; M. Blanton, unpublished data). Following irradiation, cholate-solubilized AChR-rich membrane polypeptides were resolved by SDS-PAGE. The autoradiograph of an 8% polyacrylamide slab gel (Fig. 2) shows there is signi¢cant incorporation of [
125 I]azido-cholesterol into each of the AChR subunits. In addition, there is substantial labeling of the K-subunit of the Na/KATPase (K NK , V95 kDa) and the CLC-0 chloride channel (V89 kDa). Addition of the agonist carbamylcholine ( 125 I]azido-cholesterol in the absence (3 lanes) or presence (+ lanes) of 250 WM carbamylcholine and subjected to SDS-PAGE on a 1.0 mm thick 8% slab gel. AChR subunit bands were excised following identi¢cation by staining, transferred to the wells of a 15% mapping gel and overlaid with 6 Wg of S. aureus V8 protease (see Section 2. AChR subunits were proteolytically digested as they migrated through the 4.5% acrylamide stacking gel (50 V constant voltage, transit time V3 h) and the resulting fragments were then resolved on the lower 15% acrylamide separating gel. Following electrophoresis, the mapping gel was stained with Coomassie blue R-250 and subjected to autoradiography (2 week exposure with intensifying screen). The principal [
125 I]azido-cholesterol-labeled proteolytic fragments, following the nomenclature of Blanton and Cohen [26] , are: KV8-20 (Ser-173-Glu-338); KV8-10 (Asn-339-Gly-437); LV8-22 (Ile-173/Asn-183-Glu-383) ; LV8-12 (Met-384-Ala-469); (faint band) QV8-24 (Ala-167/Trp-170-Glu-372); QV8-14 (Leu-373/Ile-413-Pro-489); QV8-12 (Ala-1 of the L-subunit of the Torpedo Na/K-ATPase); (faint band) NV8-20 (Ile-192-Glu-345); NV8-12 (Ile-192-Glu-280); NV8-11 (Lys-436-Ala-501).
Mapping the sites of [ 125 I]azido-cholesterol labeling in each AChR subunit
Limited digestion of each AChR subunit using S. aureas V8 protease reproducibly generates a set of non-overlapping fragments [23, 26] . For the AChR K-subunit four principal fragments are generated with apparent molecular weights of 20 kDa (KV8-20, Ser-173-Glu-338), 18 kDa (KV8-18, Thr-52-Glu-172), 10 kDa (KV8-10, Asn-339-Gly-437), and 4 kDa (KV8-4, Ser-1-Glu-51) [23, 29] . Inspection of the autoradiograph of a 15% acrylamide mapping gel containing the V8 protease digests of each receptor subunit (Fig. 3) reveals that [ 125 I]azido-cholesterol incorporation within the K-subunit is restricted to the fragments KV8-20 and KV8-10. The KV8-20 (Ser-173-Glu-338) fragment contains the hydrophobic membrane spanning segments M1, M2 and M3 while KV8-10 (Asn-339-Gly-437) contains a large portion of the subunits' cytoplasmic loop as well as the transmembrane segment M4. Inclusion of the agonist carbamylcholine does not alter the pattern of [
125 I]azido-cholesterol labeling of the K-subunit which remains restricted to KV8-20 and KV8-10 ( Fig. 3, + lane) . Direct counting of excised gel bands shows that in the absence of agonist 26% of [ 125 I]azido-cholesterol incorporation into the K-subunit is restricted to KV8-20 and 74% to KV8-10. In the presence of agonist, the relative incorporation is very similiar, 20 and 80% respectively. The similarity in the distribution of [ 125 I]azido-cholesterol labeling between the KV8-10 and KV8-20 fragments of the carbamylcholine treated and untreated samples indicates that [
125 I]azido-cholesterol labeling is not sensitive to the conformational state of the receptor.
Inspection of the autoradiograph of the V8 protease digests of the L-, Q-, and N-subunits (Fig. 3 ) reveals signi¢cant [
125 I]azido-cholesterol incorporation into the following fragments, using the nomenclature of Blanton and Cohen [26] : LV8-22 (Ile-173/ Asn-183-Glu-383); LV8-12 (Met-384-Ala-469); (faint band) QV8-24 (Ala-167/Trp-170-Glu-372); QV8-14 (Leu-373/Ile-413-Pro-489); QV8-12 (Ala-1 of the Lsubunit of the Torpedo Na/K-ATPase); NV8-12 (Ile-192-Glu-280); NV8-11 (Lys-436-Ala-501). Fragments LV8-22 and QV8-24 are homologous to KV8-20 in that they contain the same stretch of amino acid residues in the aligned sequences of each subunit, which includes the transmembrane segments M1, M2, and M3. Similarly, LV8-12, QV8-14, and NV8-11 are homologous to KV8-10 and contain the transmembrane segment M4. 125 I]azido-cholesterol-labeled 10 kDa V8 protease fragment of the AChR K-subunit (KV8-10, isolated from AChR labeled in the absence of carbamylcholine) was further digested in solution with trypsin and the labeled material puri¢ed by reverse-phase HPLC (A) on a Brownlee Aquapore C 4 column (100U2.1 mm) as described in Section 2. The elution of peptides was monitored by absorbance at 210 nm (solid line) and elution of 125 I by Q-counting of each 500 Wl fraction (b). HPLC fractions 36^39 were pooled and subjected to automated sequential Edman degradation (B). Sixty percent of each cycle of Edman degradation was analyzed for released 125 I (b) and 30% for released PTH-amino acids (E) with the dashed line corresponding to the exponential decay ¢t of the amount of detected PTH-amino acids. A primary peptide was detected beginning at Tyr-401 of the K-subunit (initial yield, 22 pmol; repetitive yield, 90.6%; 6430 cpm loaded on sequencing ¢lter; 1410 cpm remaining after 25 cycles). The amino acid sequence of the peptide is shown above B with the solid line indicating the limits of the M4 region.
Mapping the sites of [
125 I]azido-cholesterol incorporation to the M4 segments of the Kand Q-subunits and to the M1 segment of the K-subunit
The sites of [
125 I]azido-cholesterol labeling within the V8 protease subunit fragments KV8-20, KV8-10, and QV8-14 were further de¢ned by exhaustive proteolytic digestion with trypsin and separation of the digests by reverse-phase HPLC. In the HPLC chromatograph of the tryptic digest of KV8-10 (Fig. 4A ) the vast majority of 125 I cpm elutes in a single peak centered in fraction 38 with a corresponding peak in absorbance eluting at V93 minutes. HPLC fractions 36^39 were pooled and subjected to N-terminal amino acid sequence analysis. The major sequence detected began at KTyr-401 (initial yield, 22 pmol; repetitive yield, 90.6%). A secondary sequence was also present beginning at KSer-388, 13 residues upstream (N-terminal) of KTyr-401 (initial yield, 15 pmol; repetitive yield, 80%). In the 125 I-release pro¢le ( When the tryptic digest of KV8-20 was separated by reverse-phase HPLC (Fig. 5A ) the majority of 125 I cpm elutes in a peak centered in fraction 38 with a corresponding peak in absorbance eluting at V92 minutes. HPLC fractions 36^39 were pooled and subjected to 10 cycles of automated Edman degradation. N-Terminal sequencing identi¢ed a single sequence beginning at KIle-210 and extending into the membrane-spanning segment KM1. Based on previous studies establishing the point of elution of an V3.4 kDa tryptic fragment of KV8-20 containing KM1 [26, 27] , the KIle-210 peptide extends through KM1 and terminates at KLys-242, which is at the amino-terminal end of the M2 segment. From the HPLC chromatograph of the tryptic digest of QV8-14 ( Fig. 5B ) HPLC fractions 35^39 were pooled ( 125 I cpm peak in fractions 37/38) and sequenced for 10 cycles. Sequence analysis revealed the presence of a primary sequence beginning at QVal-446. The QVal-446 peptide extends through the transmembrane segment M4, terminating at either QArg-485 the next available tryptic cleavage site or possibly at the subunit C-terminus (Pro-489). Sequence analysis also revealed the presence of a minor secondary sequence beginning at QGlu-429, 17 residues upstream (N-terminal) to the start of the QVal-446 peptide and also presumably extending through QM4.
Discussion
Cholesterol, an essential constituent of most eukaryotic cells, is also necessary for the functional activity of many membrane proteins, including the nicotinic acetylcholine receptor [7, 9, 30] . While the requirement for cholesterol or more generally sterol [31] for AChR function is well established, the mechanism by which cholesterol modulates the structure/ function of the receptor is by no means well understood. Theories of regulation based on membrane £uidity or bilayer structure have for the most part been discounted [32^34] . Cholesterol has also been proposed to stabilize transmembrane segment secondary structure by packing of the rigid sterol ring structure into grooves of transmembrane helices [35, 36] . However in more recent structural studies of the AChR no signi¢cant di¡erences in receptor secondary structure have been detected in the absence of cholesterol [37] . Obtaining a better understanding of the role of cholesterol in AChR structure/function is further complicated by the lack of a de¢ned binding domain for sterol. It has been proposed that there are non-annular or interstitial binding sites for cholesterol which are distinct from the lipid^protein interface [16] and even extramembrane binding sites [15] .
In the present study, we have employed a photoreactive analog of cholesterol [3K-(4-azido-3-[ 125 I]iodosalicylic)-cholest-5-ene ([ 125 I]azido-cholesterol)], to identify the binding domain for cholesterol in the AChR. Based upon the extremely lax structure^activity requirements for cholesterol [31, 33, 34] , [ 125 I]azido-cholesterol serves not only as a probe on the cholesterol binding domain, but is probably also a functional substitute for cholesterol. For example, in reconstitution studies, cholesterol analogs derivatized at the 3P position with substituents as small as sulfate and as large as phosphatidylcholine, were shown to support AChR activity [34] . Sunshine and McNamee [31] reported that neutral lipids as structurally dissimiliar to cholesterol as vitamin D were also found to support AChR function. In addition, supportive evidence that azido-cholesterol is a functional substitute for cholesterol was obtained by examining the ability of the AChR to undergo conformational transitions in the presence of the cholesterol probe. The pattern and extent of photoincorporation of 3-tri£uoromethyl-3-(m[
125 I]iodophenyl) diazirine ([ 125 I]TID) into the AChR can be used as a diagnostic indicator of the conformational state of the AChR [28, 29] . In the presence of 100 WM azido-cholesterol and in the absence of agonist, the pattern and extent of [
125 I]TID incorporation into receptor subunits was consistent with the AChR being in the resting state conformation (data not shown). The implication of this result is that azido-cholesterol does not shift the conformational equilibrium of the AChR. In addition, as judged by the pattern of [ 125 I]TID incorporation in the presence of both agonist and azido-cholesterol, the cholesterol probe did not inhibit the ability of the receptor to undergo conformational transitions. Together, these results provide indirect evidence that azido-cholesterol supports AChR activation.
In the AChR K-subunit, sites of [ 125 I]azido-cholesterol incorporation are restricted to the membranespanning segments KM1 and KM4. Previous studies have established that the M1, M3, and M4 segments of each receptor subunit de¢ne the lipid^protein interface of the AChR [26, 38, 39] . The observation that [ 125 I]azido-cholesterol incorporates into the AChR subunits equally on a molar basis for both native AChR membranes and a¤nity puri¢ed reconstituted receptors indicate that the labeling is proportional to mass and, by implication, to the surface area exposed to lipid. Incorporation of [
125 I]azido-cholesterol into the K-subunit of the Na/K-ATPase and the CLC-0 chloride channel (Fig. 2) , both multi-membrane spanning polypeptides, provides additional support that labeling is proportional to the surface area exposed to lipid. While these results support the existence of a cholesterol binding domain at the AChR lipid^protein interface, they do not support the existence of non-annular binding sites for cholesterol that are distinct from the lipid^protein interface nor are they consistent with the presence of extramembrane sterol binding sites.
For AChRs labeled with [ 125 I]azido-cholesterol in the presence and in the absence of the agonist carbamylcholine, no signi¢cant di¡erences in either the pattern or extent of incorporation into AChR subunits or subunit proteolytic fragments were detected. Similar results were observed with the cholesterol photoa¤nity probe [ 3 H]cholesteryl diazoacetate ( [19] ; but see Fernandez et al. [20] ). These data suggest that structural transitions in the receptor upon addition of agonist do not signi¢cantly change the surface area of the receptor exposed to the steroid. In addition, cholesterol does not appear to induce any signi¢cant secondary structural changes to the AChR transmembrane segments [37] . Therefore, while the presence of cholesterol (sterol) is necessary for the receptor to undergo conformational transitions (reviewed in [30] ), these results suggest a mechanism of cholesterol modulation that involves subtle changes in the structure and/or orientation of the lipid-exposed segments. One possibility is that cholesterol may a¡ect the interaction/packing of transmembrane segments [35] and these interactions are in all likelihood critical in facilitating the conformational transitions of the AChR. Localized interactions between the lipid-exposed segments M4, M3, and M1 and the channel-lining M2 segment are clearly important in mediating the agonist-induced transitions necessary for channel opening [40, 41] . Substitution of lipid-exposed residues [42] as well as the interaction of agents with the lipid^protein interface [43, 44] also appear to modulate these interactions as judged by e¡ects on AChR channel properties. Cholesterol does not appear to act by altering the secondary structure of the membrane-spanning segments in any signi¢cant fashion [37] , but may instead act as a sort of`molecular grease' in facilitating subtle structural movements of the transmembrane segments that occur during conformational transitions. A sterol binding site at the interfaces of membrane-spanning segments [45] is consistent with the results of Dreger et al. [15] . In this study, it was found that proteolytic removal of the extramembrane portions of the AChR resulted in a loss of receptor-speci¢c binding sites for the spin-labeled sterol adrostane. The authors interpreted these results as suggesting the existence of extramembrane sterol binding sites. An alternative explanation is that extramembrane regions and in particular the loops connecting the transmembrane segments are critically important in stabilizing the interaction/ packing of membrane-spanning segments. Removal of the loops connecting the transmembrane segments would serve to destabilize their packing and result in a disruption of cholesterol binding sites. Along these lines, future cross-linking studies with analogs of cholesterol may be useful in further de¢ning the sterol binding domain as well as the structure of the AChR transmembrane domain.
In summary, this study represents an important step in elucidating the molecular details of the cholesterol^AChR interaction. Sites of incorporation of the photoactivatable cholesterol analog [ 125 I]azidocholesterol were localized to transmembrane segments which form the lipid^protein interface of the AChR. Additional work will be necessary to identify speci¢c amino acid residues in each lipid-exposed transmembrane segment which interact with cholesterol. Nonetheless, these results support a possible mechanism for the requirement of cholesterol for AChR function that involves sterol facilitating the packing/interaction of membrane-spanning K-helical segments.
